Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Restructuring Benefits and Charges (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Restructuring Reserve [Roll Forward]
Beginning balance		$ 25	[1]	$ 21		$ 45
Provision/(benefit)		6		33		8
Utilization and other	[2]	(14)		(16)		(32)
Ending balance		15	[1]	25	[1]	21
Restructuring Reserve, Settled without Cash		(2)		(13)		0
Other current liabilities
Restructuring Reserve [Roll Forward]
Accrued expenses		5		14
Other non-current liabilities
Restructuring Reserve [Roll Forward]
Other noncurrent liabilities		10		11
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning balance		23	[1]	21		45
Provision/(benefit)	[3],[4]	3		17		8
Utilization and other	[2]	(12)		(15)		(32)
Ending balance		14	[1]	23	[1]	21
Restructuring Reserve, Settled without Cash		0		0
Exit Costs
Restructuring Reserve [Roll Forward]
Beginning balance		2	[1]	0		0
Provision/(benefit)		1		3		0
Utilization and other	[2]	(2)		(1)		0
Ending balance		1	[1]	2	[1]	$ 0
Restructuring Reserve, Settled without Cash		0		0
Facility Closing
Restructuring Reserve [Roll Forward]
Provision/(benefit)		2		13
Restructuring Reserve, Settled without Cash		(2)		$ (13)
Employee Severance and Exit Costs
Restructuring Reserve [Roll Forward]
Contractual obligation		7
Payments expected in 2022		6
Payments expected thereafter		$ 1

[1] At December 31, 2022 and 2021, included in Accrued Expenses ($5 million and $14 million, respectively) and Other noncurrent liabilities ($10 million and $11 million, respectively).

[2] Includes adjustments for foreign currency translation.

[3] The restructuring charges are associated with the following: •For the year ended December 31, 2022, Manufacturing/research/corporate of $2 million and International of $4 million. •For the year ended December 31, 2021, Manufacturing/research/corporate of $21 million and International of $12 million. •For the year ended December 31, 2020, Manufacturing/research/corporate of $8 million.

[4] The restructuring charges for the year ended December 31, 2022 are primarily related to employee termination and exit costs associated with cost-reduction and productivity initiatives in certain international markets, as well as asset impairment charges primarily related to the consolidation of manufacturing sites in China.     The restructuring charges for the year ended December 31, 2021 are primarily related to the realignment of our international operations and other cost-reduction and productivity initiatives.     The restructuring charges for the year ended December 31, 2020 are primarily related to CEO transition-related costs and other cost-reduction and productivity initiatives.